Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Aadi Bioscience, Inc.
  6. News
  7. Summary
    AADI   US00032Q1040

AADI BIOSCIENCE, INC.

(AADI)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
12.16 USD   -8.23%
06/24AADI BIOSCIENCE : Corporate Overview
PU
06/24Aadi Bioscience to Join Russell 2000 and Russell 3000 Indexes
AQ
06/23Aadi Bioscience to Join Russell 2000, Russell 3000 Indexes
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $2.3M

05/12/2022 | 08:57am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about AADI BIOSCIENCE, INC.
06/24AADI BIOSCIENCE : Corporate Overview
PU
06/24Aadi Bioscience to Join Russell 2000 and Russell 3000 Indexes
AQ
06/23Aadi Bioscience to Join Russell 2000, Russell 3000 Indexes
MT
06/23Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes
AQ
06/17AADI BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/01Aadi Bioscience to Present at the Jefferies Global Healthcare Conference
AQ
05/31Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corp..
AQ
05/31Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corp..
CI
05/26Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial ..
AQ
05/26Aadi Bioscience, Inc. Announces Exploratory Biomarker Data from Patients in Its AMPECT ..
CI
More news
Analyst Recommendations on AADI BIOSCIENCE, INC.
More recommendations
Financials (USD)
Sales 2022 14,4 M - -
Net income 2022 -60,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,26x
Yield 2022 -
Capitalization 255 M 255 M -
Capi. / Sales 2022 17,7x
Capi. / Sales 2023 16,2x
Nbr of Employees 54
Free-Float 86,4%
Chart AADI BIOSCIENCE, INC.
Duration : Period :
Aadi Bioscience, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 12,16 $
Average target price 43,50 $
Spread / Average Target 258%
EPS Revisions
Managers and Directors
Neil P. Desai President, CEO, Secretary & Director
Scott M. Giacobello Treasurer, Chief Financial & Accounting Officer
Caley M. Castelein Chairman
Loretta M. Itri Chief Medical Officer
Berta Grigorian Vice President-Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
AADI BIOSCIENCE, INC.-49.65%255
CSL LIMITED-7.99%90 814
SAMSUNG BIOLOGICS CO.,LTD.-7.97%45 825
WUXI BIOLOGICS (CAYMAN) INC.-24.42%41 498
BIOGEN INC.-11.67%31 038
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-19.19%24 084